Copyright Reports & Markets. All rights reserved.

Global Edema Clinical Trials Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Edema Clinical Trials Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Systemic
      • 1.4.3 Local
    • 1.5 Market by Application
      • 1.5.1 Global Edema Clinical Trials Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Medical Research Organization
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Edema Clinical Trials Market Size
    • 2.2 Edema Clinical Trials Growth Trends by Regions
      • 2.2.1 Edema Clinical Trials Market Size by Regions (2019-2025)
      • 2.2.2 Edema Clinical Trials Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Edema Clinical Trials Market Size by by Players
      • 3.1.1 Global Edema Clinical Trials Revenue by by Players (2014-2019)
      • 3.1.2 Global Edema Clinical Trials Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Edema Clinical Trials Market Concentration Ratio (CR5 and HHI)
    • 3.2 Edema Clinical Trials Key Players Head office and Area Served
    • 3.3 Key Players Edema Clinical Trials Product/Solution/Service
    • 3.4 Date of Enter into Edema Clinical Trials Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Edema Clinical Trials Market Size by Type (2014-2019)
    • 4.2 Global Edema Clinical Trials Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Edema Clinical Trials Market Size (2014-2019)
    • 5.2 Edema Clinical Trials Key Players in North America
    • 5.3 North America Edema Clinical Trials Market Size by Type
    • 5.4 North America Edema Clinical Trials Market Size by Application

    6 Europe

    • 6.1 Europe Edema Clinical Trials Market Size (2014-2019)
    • 6.2 Edema Clinical Trials Key Players in Europe
    • 6.3 Europe Edema Clinical Trials Market Size by Type
    • 6.4 Europe Edema Clinical Trials Market Size by Application

    7 China

    • 7.1 China Edema Clinical Trials Market Size (2014-2019)
    • 7.2 Edema Clinical Trials Key Players in China
    • 7.3 China Edema Clinical Trials Market Size by Type
    • 7.4 China Edema Clinical Trials Market Size by Application

    8 Japan

    • 8.1 Japan Edema Clinical Trials Market Size (2014-2019)
    • 8.2 Edema Clinical Trials Key Players in Japan
    • 8.3 Japan Edema Clinical Trials Market Size by Type
    • 8.4 Japan Edema Clinical Trials Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Edema Clinical Trials Market Size (2014-2019)
    • 9.2 Edema Clinical Trials Key Players in Southeast Asia
    • 9.3 Southeast Asia Edema Clinical Trials Market Size by Type
    • 9.4 Southeast Asia Edema Clinical Trials Market Size by Application

    10 India

    • 10.1 India Edema Clinical Trials Market Size (2014-2019)
    • 10.2 Edema Clinical Trials Key Players in India
    • 10.3 India Edema Clinical Trials Market Size by Type
    • 10.4 India Edema Clinical Trials Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Edema Clinical Trials Market Size (2014-2019)
    • 11.2 Edema Clinical Trials Key Players in Central & South America
    • 11.3 Central & South America Edema Clinical Trials Market Size by Type
    • 11.4 Central & South America Edema Clinical Trials Market Size by Application

    12 International Players Profiles

    • 12.1 Otsuka Holdings
      • 12.1.1 Otsuka Holdings Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Edema Clinical Trials Introduction
      • 12.1.4 Otsuka Holdings Revenue in Edema Clinical Trials Business (2014-2019))
      • 12.1.5 Otsuka Holdings Recent Development
    • 12.2 Roche
      • 12.2.1 Roche Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Edema Clinical Trials Introduction
      • 12.2.4 Roche Revenue in Edema Clinical Trials Business (2014-2019)
      • 12.2.5 Roche Recent Development
    • 12.3 CMP Pharma
      • 12.3.1 CMP Pharma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Edema Clinical Trials Introduction
      • 12.3.4 CMP Pharma Revenue in Edema Clinical Trials Business (2014-2019)
      • 12.3.5 CMP Pharma Recent Development
    • 12.4 Syneos Health
      • 12.4.1 Syneos Health Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Edema Clinical Trials Introduction
      • 12.4.4 Syneos Health Revenue in Edema Clinical Trials Business (2014-2019)
      • 12.4.5 Syneos Health Recent Development
    • 12.5 GlaxoSmithKline
      • 12.5.1 GlaxoSmithKline Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Edema Clinical Trials Introduction
      • 12.5.4 GlaxoSmithKline Revenue in Edema Clinical Trials Business (2014-2019)
      • 12.5.5 GlaxoSmithKline Recent Development
    • 12.6 Boehringer Ingelheim
      • 12.6.1 Boehringer Ingelheim Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Edema Clinical Trials Introduction
      • 12.6.4 Boehringer Ingelheim Revenue in Edema Clinical Trials Business (2014-2019)
      • 12.6.5 Boehringer Ingelheim Recent Development
    • 12.7 Sam Chun Dang Pharm
      • 12.7.1 Sam Chun Dang Pharm Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Edema Clinical Trials Introduction
      • 12.7.4 Sam Chun Dang Pharm Revenue in Edema Clinical Trials Business (2014-2019)
      • 12.7.5 Sam Chun Dang Pharm Recent Development
    • 12.8 Endo International
      • 12.8.1 Endo International Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Edema Clinical Trials Introduction
      • 12.8.4 Endo International Revenue in Edema Clinical Trials Business (2014-2019)
      • 12.8.5 Endo International Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Edema refers to the body's tissues clearance with the accumulation of excess fluid organizational swelling.Edema can be divided into systemic and local.Systemic edema (usually pitting) occurs when fluid is distributed diffusely between tissues in the body.Fluid accumulation in local interstitial space presented local edema.Occur in the body cavity called effusion, such as pleural effusion, peritoneal effusion, pericardial effusion.In general, the term edema does not include edema of the internal organs, such as cerebral edema, pulmonary edema, etc.The purpose of the edema clinical trial is to assess the efficacy of the drug delivery system, such as baseline vision and mean changes in edema.
      In 2018, the global Edema Clinical Trials market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Edema Clinical Trials status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Edema Clinical Trials development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Otsuka Holdings
      Roche
      CMP Pharma
      Syneos Health
      GlaxoSmithKline
      Boehringer Ingelheim
      Sam Chun Dang Pharm
      Endo International

      Market segment by Type, the product can be split into
      Systemic
      Local

      Market segment by Application, split into
      Hospital
      Medical Research Organization
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Edema Clinical Trials status, future forecast, growth opportunity, key market and key players.
      To present the Edema Clinical Trials development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Edema Clinical Trials are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now